i-SENS, Inc. (KOSDAQ:099190)

Market Cap	483.68B +3.6%
Revenue (ttm)	314.31B +5.1%
Net Income	-5.79B
EPS	-209.91
Shares Out	28.76M
PE Ratio	n/a
Forward PE	105.79
Dividend	100.00 (0.64%)
Ex-Dividend Date	Dec 29, 2025

Volume	72,378
Open	15,580
Previous Close	15,560
Day's Range	15,580 - 17,000
52-Week Range	14,600 - 27,600
Beta	0.87
Analysts	Buy
Price Target	36,000.00 (+114.03%)
Earnings Date	Aug 14, 2026

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of sensors and measuring instruments based on electrochemical and biosensor technologies in South Korea and internationally. The company offers blood glucose monitoring devices; measuring instruments and point-of-care diagnostic devices (POCT), biosensor technologies, diabetes care, acute care, and coagulation care devices; veterinary care devices; and IVD systems. It also provides SmartLog, diabetes management software for mobile and PC. The company was founded in 2000 and is headq...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2000
• Employees: 887
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099190

Financial Performance

In 2025, i-SENS's revenue was 315.44 billion, an increase of 8.35% compared to the previous year's 291.14 billion. Losses were -5.15 billion, 187.0% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for 099190 stock is "Buy." The 12-month stock price target is ₩36,000, which is an increase of 114.03% from the latest price.

Price Target

₩36,000

(114.03% upside)

Analyst Consensus: Buy